What is OncoGaze?
OncoGaze™ is Acurion’s proprietary diagnostic platform that transforms routine pathology slides into powerful genomic insights—detecting critical biomarkers like HRD with high accuracy and unprecedented speed.
Built by oncologists and computational pathologists, OncoGaze™ integrates seamlessly into clinical workflows to support earlier, more informed treatment decisions in oncology.
Precision from every slide.
Developed by Experts.
Designed for Impact.
How it works:
OncoGaze provides a predictive analysis of HRD status using routine pathology slides within minutes:
- Digitized Pathology SlidesStandard H&E-stained slides are scanned–no new tissue required.
- AI-Powered Image AnalysisOncoGaze™ analyzes slide features using deep learning algorithms trained on thousands of annotated samples.
- Biomarker IdentificationPredicts presence of actionable biomarkers such as HRD that are linked to treatment pathways.
Who Does OncoGaze Serve?
Explore OncoGaze’s impact across breast, ovarian, and pancreatic cancers—where early precision matters most
Let's bring precision oncology forward – together.
Explore how Acurion is driving immediate precision for optimal care.
Contact us for a demo of OncoGaze.